Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Mar 16, 2025; 17(3): 97016
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.97016
Table 1 Statistical analysis using the Pearson correlation test
Category
Measurement
Crohn’s disease (n = 67)
Ulcerative colitis (n = 34)
Baseline characteristicsGenderMale: 45%; Female: 55%Male: 50%; Female: 50%
Age (years), mean ± SD35.4 ± 12.740.2 ± 14.5
BMI (kg/m²), mean ± SD23.1 ± 3.524.0 ± 4.1
Disease duration, median (IQR), year7 (3-12)5 (2-10)
Smoking statusSmokers: 30%; Non-smokers: 70%Smokers: 20%; Non-smokers: 80%
Medication useBiologics: 60%; Immunomodulators: 40%Biologics: 50%; Immunomodulators: 50%
Disease locationIleum: 45%; Colon: 35%; Ileocolon: 20%Left-sided: 60%; Pancolitis: 40%
IUS and endoscopy inflammation signsIUS inflammation vs endoscopic inflammationP: 0.004; R: 0.851 (0.70-0.94); N: 56, 83%P: 0.007; R: 0.842 (0.78-0.96); N: 24, 72%
Limberg endoscopic score > 2 and deep ulcersP: 0.079P: 0.089
IUS inflammation and clinical scoresIntestinal BWT vs HBI score > 4 (CD). Intestinal BWT vs Mayo score > 7 (UC)P: 0.6; R: 0.18 (0.02-0.35); N: 56, 83%P: 0.27; R: 0.230 (0.117-0.527); N: 23, 70%
IUS and endoscopic remissionEndoscopic remission vs IUS remissionP: 0.03; R: 0.656 (0.47-0.87); N: 9, 13%P: 0.04; R: 0.62 (0.44-0.71); N: 6, 19%
IUS and endoscopic locationSame location in endoscopy and IUSP: 0.04; R: 0.53 (0.31-0.65); N: 48, 71%P: 0.035; R: 0.647 (0.434-0.772); N: 25, 76%
Collection in IUS and CT scanCollection in IUS vs collection in CT scanP: < 0.01; R: 0.835 (0.699-0.969); N: 6, 9%P: < 0.01; R: 0.835 (0.699-0.969); N: 10, 14%
Bowel thickness and endoscopic scoresBWT > 7 mm vs CDEIS > 15 (CD). BWT > 7 mm vs UCEIS > 6 (UC)P: 0.053; R: 0.452 (0.2-0.61); N: 22, 47%P: 0.008; R: 0.87 (0.759-0.94); N: 16, 47%
Inflammatory activity in IUS and histologyInflammatory activity in IUS vs histologyP: 0.012; R: 0.72 (0.68-0.84); N: 53, 87%P: 0.21; R: 0.25 (0.13-0.317); N: 24, 72%
Detailed IUS and endoscopic findingsBowel wall thickness, mean ± SD5.4 ± 1.2 mm4.8 ± 1.1 mm
Vascularity (Doppler)Increased: 65%; Normal: 35%Increased: 55%; Normal: 45%
Mucosal ulcerationPresent: 40%; Absent: 60%Present: 35%; Absent: 65%
Stratification lossPresent: 30%; Absent: 70%Present: 25%; Absent: 75%
Fistulas/abscessesPresent: 15%; Absent: 85%Present: 10%; Absent: 90%